Lacy J - Search Results

1

Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.

Li J, Yao X, Kortmansky JS, Fischbach NA, Stein S, Deng Y, Zhang Y, Doddamane I, Karimeddini D, Hochster HS, Lacy J. Li J, et al. Among authors: lacy j. Am J Clin Oncol. 2017 Apr;40(2):146-151. doi: 10.1097/COC.0000000000000114. Am J Clin Oncol. 2017. PMID: 25144267 Clinical Trial.

2

A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma.

Mayer T, Lacy J, Baehring J. Mayer T, et al. Among authors: lacy j. Clin Med Oncol. 2008;2:455-9. doi: 10.4137/cmo.s827. Epub 2008 Jun 9. Clin Med Oncol. 2008. PMID: 21892317 Free PMC article.

3

FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Gunturu KS, Yao X, Cong X, Thumar JR, Hochster HS, Stein SM, Lacy J. Gunturu KS, et al. Among authors: lacy j. Med Oncol. 2013 Mar;30(1):361. doi: 10.1007/s12032-012-0361-2. Epub 2012 Dec 28. Med Oncol. 2013. PMID: 23271209 Review.

4

Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity.

Zhang Y, Hochster H, Stein S, Lacy J. Zhang Y, et al. Among authors: lacy j. Exp Hematol Oncol. 2015 Oct 7;4:29. doi: 10.1186/s40164-015-0025-y. eCollection 2015. Exp Hematol Oncol. 2015. PMID: 26451276 Free PMC article.

5

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.

Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, Staugaard C, Indukala D, Boustani AM, Patel V, Cha CH, Salem RR, Chang B, Hochster HS, Lacy J. Stein SM, et al. Among authors: lacy j. Br J Cancer. 2016 Mar 29;114(7):737-43. doi: 10.1038/bjc.2016.45. Br J Cancer. 2016. PMID: 27022826 Free PMC article. Clinical Trial.

6

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, Hong TS, Shridhar R, Chau I, van Eijck CH, Koerkamp BG. Suker M, et al. Among authors: lacy j. Lancet Oncol. 2016 Jun;17(6):801-810. doi: 10.1016/S1470-2045(16)00172-8. Epub 2016 May 6. Lancet Oncol. 2016. PMID: 27160474 Free PMC article. Review.

7

Genomic mutations and histopathologic biomarkers in Y⁹⁰ radioembolization for chemorefractory colorectal liver metastases.

Dendy MS, Ludwig JM, Kokabi N, Stein SM, Lacy J, Hochster HS, Kim HS. Dendy MS, et al. Among authors: lacy j. Oncotarget. 2018 Aug 21;9(65):32523-32533. doi: 10.18632/oncotarget.25992. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197760 Free PMC article.

8

Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer.

Mancini BR, Stein S, Lloyd S, Rutter CE, James E, Chang BW, Lacy J, Johung KL. Mancini BR, et al. Among authors: lacy j. J Gastrointest Oncol. 2018 Dec;9(6):982-988. doi: 10.21037/jgo.2018.04.03. J Gastrointest Oncol. 2018. PMID: 30603116 Free PMC article.

9

Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.

Uhlig J, Sellers CM, Cha C, Khan SA, Lacy J, Stein SM, Kim HS. Uhlig J, et al. Among authors: lacy j. Ann Surg Oncol. 2019 Jul;26(7):1993-2000. doi: 10.1245/s10434-019-07175-4. Epub 2019 Jan 28. Ann Surg Oncol. 2019. PMID: 30693451

10

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

Fuchs CS, Shitara K, Di Bartolomeo M, Lonardi S, Al-Batran SE, Van Cutsem E, Ilson DH, Alsina M, Chau I, Lacy J, Ducreux M, Mendez GA, Alavez AM, Takahari D, Mansoor W, Enzinger PC, Gorbounova V, Wainberg ZA, Hegewisch-Becker S, Ferry D, Lin J, Carlesi R, Das M, Shah MA; RAINFALL Study Group. Fuchs CS, et al. Among authors: lacy j. Lancet Oncol. 2019 Mar;20(3):420-435. doi: 10.1016/S1470-2045(18)30791-5. Epub 2019 Feb 1. Lancet Oncol. 2019. PMID: 30718072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters